Stoxx Europe 600 Index Adds 0.6 Percent

The video discusses market trends, focusing on the healthcare industry's movements and the impact of the Pfizer Allegan deal termination. It highlights the performance of AstraZeneca, Glaxo, and Callbox, a lesser-known chocolate company. The video also analyzes the Footsie 350's resilience amid Brexit concerns, emphasizing its composition of energy and mining stocks and the effect of declining sterling.

What was the impact of the Pfizer Allegan deal termination on the healthcare industry?

• It resulted in a merger between Astra Zeneca and Glaxo.

• It had no impact on the healthcare industry.

• It led to an increase in Glaxo shares by roughly 5%.

• It caused a significant drop in all healthcare stocks.

Which company experienced its biggest share rise since 2003 due to a profit beat?

• Unilever

• Callbox

• Hershey

• Cadburys

What percentage of the world's chocolate is produced by the company discussed in the second section?

• 75%

• 50%

• 25%

• 10%

Why are investors in the Footsie 350 not worried about Brexit?

• The Footsie 350 has a high valuation relative to the stock 600.

• The Footsie 350 has no exposure to the UK market.

• The Footsie 350 is heavily invested in technology stocks.

• The Footsie 350 is unaffected by global market trends.

What are the two main reasons for the Footsie 350's performance?

• Strong global partnerships and high consumer demand.

• Energy and mining stocks, and declining sterling.

• Low interest rates and government subsidies.

• High technology stock investments and strong UK economy.